Linked here is a detailed quantitative analysis of Pfizer Inc. (PFE). Below are some highlights from the above linked analysis: Company Description: Pfizer Inc. ranks as one of the world's largest pharmaceutical …
Analysis
Ibrance is yet to take off in the high demand European market. Growth should accelerate going forward. Bococizumab will only affect earnings in the near term. Pfizer's pipeline has the ability to recover these lost …
Pfizer
PFE Stock: This Competitor Set to Soar? Buying the right stock at the right time can be the difference maker in one’s investment account. If I had purchased Pfizer Inc. (NYSE:PFE) stock in 2009 at $9.00 when everybody …
Pfizer
Thursday's announcement marks Pfizer's third proposed biosimilar pipeline molecule to announce positive top-line results within the past four months. Congressional Republicans who scrapped plans to overhaul the Office of …
British pharmaceutical company AstraZeneca Plc (NYSE ADR: AZN) once again rebuffed a takeover bid from rival Pfizer today (Tuesday) when the company announced its forward strategy and revenue projections. …
AstraZeneca
Disclosure: I am/we are long CSCO, PFE, VZ. I wrote this article myself, …
SDI
in collaboration with Pfizer (PFE), to treat multiple pain indications, including osteoarthritis, lower back and cancer pain. CoLucid went …
Eli Lilly
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc (Symbol: PFE). So this week we highlight one interesting put contract, and one …
Drugmaker Pfizer Inc. (NYSE:PFE) is rebounding with the broader stock market today -- not to mention some sector peers -- amid news the company plans to invest $350 million in the first biotech center in China. Plus, …
Pfizer
Pfizer Inc. (NYSE:PFE) was upgraded by equities researchers at Barclays PLC from an “equal weight” rating to an “overweight” rating in a report released on Tuesday. The firm currently has a $38.00 price objective on the …
BNS1mon